Skip to Main content Skip to Navigation
Journal articles

Clinical relevance of amphiregulin and VEGF in primary breast cancers.

Abstract : The characterization of novel prognostic markers in breast cancer is necessary to improve the identification of high-risk populations. In our study, the prognostic significance of VEGF and amphiregulin (AR) was investigated and compared to conventional prognostic factors in primary breast cancers. The analysis was performed using enzyme-linked immuno-assay in a series of 193 patients, and univariate and multivariate analysis were performed in the overall population as well as in pre- and post-menopausal patients subdivided in node-negative (N-) and node-positive (N+) subsets. AR (median, 44.8 pg/mg protein) appeared strongly correlated with progesterone receptors (PgR) (p = 0.0018) in the premenopausal N+ population, and with uPA (p= 0.020) and VEGF (p= 0.0053) in the postmenopausal/N+ patients. Despite these attractive data, AR expression was not significant for recurrence or survival outcome. Data revealed strong correlation between VEGF and uPA, and PAI-1, in the N+ population. Moreover, patients with high VEGF levels displayed poor outcome, with an increased risk for N+ subset. These data were confirmed by multivariate analysis that presented histologic grade (HR, 10.55, p = 0.001) and VEGF (HR, 3.89, p = 0.03) as the prominent prognostic markers for overall survival for the N+ population. Furthermore, infiltrating ductal carcinomas (IDC) were shown to express higher levels of both uPA (p < 0.0001) and VEGF (p = 0.002) than intralobular carcinomas. This retrospective study reinforces the pejorative biological role of VEGF in the progression of breast tumors. Our data also suggest that VEGF and uPA might play particular role in the biology and progression of IDC.
Document type :
Journal articles
Complete list of metadatas

Cited literature [56 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00156292
Contributor : Yolande Berthois <>
Submitted on : Wednesday, June 20, 2007 - 3:47:49 PM
Last modification on : Tuesday, January 30, 2018 - 1:30:34 AM
Long-term archiving on: : Friday, November 25, 2016 - 3:12:25 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Sylvie Desruisseau, Jaqueline Palmari, Corinne Giusti, Sylvie Romain, Pierre-Marie Martin, et al.. Clinical relevance of amphiregulin and VEGF in primary breast cancers.. International Journal of Cancer, Wiley, 2004, 111 (5), pp.733-40. ⟨10.1002/ijc.20312⟩. ⟨inserm-00156292⟩

Share

Metrics

Record views

210